X. Li
Impact in
-
- Cancer Immunotherapy and Biomarkers
- Lung Cancer Research Studies
- Colorectal Cancer Treatments and Studies
- Pancreatic and Hepatic Oncology Research
-
- Lung Cancer Treatments and Mutations
Papers in
- Oncology 20
- Cancer Immunotherapy and Biomarkers 13
- Lung Cancer Research Studies 10
- Colorectal Cancer Treatments and Studies 6
- Peptidase Inhibition and Analysis 4
-
- Lung Cancer Treatments and Mutations 14
- Lung Cancer Diagnosis and Treatment 3
X. Li
31 papers receiving 202 citations
Peers
Comparison fields: 5 of 40
- Oncology 149
- Pulmonary and Respiratory Medicine 108
- Cancer Research 19
- Immunology 24
- Pathology and Forensic Medicine 20
Countries citing papers authored by X. Li
This map shows the geographic impact of X. Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by X. Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites X. Li more than expected).
Fields of papers citing papers by X. Li
This network shows the impact of papers produced by X. Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by X. Li. The network helps show where X. Li may publish in the future.
Co-authorship network
The 25 scholars most cited alongside X. Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 2 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 0 | |
| 4 | 2024 | 3 | |
| 5 | 2024 | 4 | |
| 6 | 2024 | 6 | |
| 7 | 2023 | 4 | |
| 8 | 2023 | 17 | |
| 9 | 2023 | 2 | |
| 10 | 2023 | 5 | |
| 11 | 2022 | 3 | |
| 12 | 2022 | 1 | |
| 13 | 2022 | 10 | |
| 14 | 2022 | 5 | |
| 15 | 2021 | 3 | |
| 16 | 2021 | 10 | |
| 17 | 2021 | 12 | |
| 18 | 2020 | 10 | |
| 19 | 2020 | 7 | |
| 20 | 2019 | 2 |
About X. Li
X. Li is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Complementary and alternative medicine, Neurology and Orthopedics and Sports Medicine, having authored 34 papers that have together received 204 indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (14 papers), Cancer Immunotherapy and Biomarkers (13 papers), Lung Cancer Research Studies (10 papers), Colorectal Cancer Treatments and Studies (6 papers), Peptidase Inhibition and Analysis (4 papers), Musculoskeletal pain and rehabilitation (3 papers), Cancer therapeutics and mechanisms (3 papers) and Lung Cancer Diagnosis and Treatment (3 papers). The work is most often cited by research in Oncology (149 citations), Pulmonary and Respiratory Medicine (108 citations), Cancer Research (19 citations), Immunology (24 citations) and Pathology and Forensic Medicine (20 citations). X. Li has collaborated with scholars based in China, United States and Australia. Frequent co-authors include Jian Fang, Ying Cheng, G. Chen, Jiuwei Cui, Yueyin Pan, Shun Lü, Chunmei Bai, Lin Wu, Fan Yang and Xingxiang Xu. Their work appears in journals such as Annals of Oncology, Journal of Thoracic Oncology, ESMO Open, Journal of Orthopaedic Surgery and Research and HemaSphere.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.